# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria

Extent: E+W+S+N.I.

At least one of the following four:
Demonstration of Toxoplasma gondii in body tissues or fluids
Detection of Toxoplasma gondii nucleic acid in a clinical specimen
Toxoplasma gondii specific antibody response (IgM, IgG, IgA) in a newborn
Persistently stable IgG Toxoplasma gondii titres in an infant (< 12 months of age)

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.47/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.47/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.